| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |